Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 August 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Physical, mental, and social problems high with Hep C antivirals

The latest issue of the European Journal of Gastroenterology & Hepatology shows high adverse effects with antiviral therapy in patients with Hep C, that worsen their private and professional relationships, and impact on adherence.

News image

fiogf49gjkf04

The Hepatitis C virus can be successfully treated in up to 60% of infected patients.

However, treatment is long and is associated with significant side-effects.

Dr Susan Zickmund investigated difficulties with this treatment as it is an important factor in patient adherence.

The investigative team enrolled patients receiving Hepatitis C treatment in a tertiary referral center in a cross-sectional study.

The team collected demographic data, functional and emotional status, and co-morbidities from patients or from the medical records.

All participants underwent a semistructured interview, which was analyzed by blinded coders.

A total of 65 patients with a mean age of 46 years, of which 39% were women, were enrolled.

80% described moderate to severe problems attributed to treatment
European Journal of Gastroenterology & Hepatology

The team found that 80% described moderate to severe problems attributed to treatment.

There was a predominance of physical difficulties, including fatigue in 74% of cases, and flu-like symptoms in 32%.

The investigators observed that 38% of patients experienced depression during treatment.

In 31% of cases, physical or emotional problems forced patients to quit their jobs or reduce employment.

The team noted that a fifth of patients attributed deteriorating relationships with friends and family to adverse treatment effects.

Necessary lifestyle adjustments, such as alcohol abstinence, caused frictions with friends in 22% of the participants.

Dr Zickmund's team concluded, “Our findings show a high prevalence of significant adverse effects in patients undergoing antiviral therapy.”

“Whereas the nature and severity of these adverse reactions is consistent with earlier reports, we identified implications with worsening private and professional relationships.”

“To encourage appropriate levels of adherence, healthcare providers should seek information about these indirect treatment effects as they monitor their patients on therapy.”

Eur J Gastroenterol & Hepatol 2006: 18(4): 381
23 March 2006

Go to top of page Email this page Email this page to a colleague

 24 August 2017 
Bariatric surgery liver biopsies
 24 August 2017 
Guidelines for the management of inherited polyposis syndromes
 24 August 2017 
Steatosis in bariatric surgery candidates with NAFLD
 23 August 2017 
Outcomes of bowel cancer screening with a fecal immunochemical test
 23 August 2017 
Arterial stiffness in NAFLD
 23 August 2017 
Colectomy rates in patients with ulcerative colitis
 22 August 2017 
Improving the diagnostic accuracy of severe liver fibrosis in NAFLD
 22 August 2017 
New therapies to manage Hep B
 22 August 2017 
Survival in patients with Lynch syndrome
 21 August 2017 
Improving medication adherence in IBD
 21 August 2017 
Treatments for chronic idiopathic constipation
 21 August 2017 
Ethnic disparities for chronic Hep C survival
 18 August 2017 
Proteomic analysis of IBD
 18 August 2017 
Pediatric intestinal failure
 18 August 2017 
Anti-TNF treatment and bowel resection in Crohn's
 17 August 2017 
Outcomes of ulcerative colitis patients undergoing pouch surgery
 17 August 2017 
Mortality in patients with asymptomatic pancreatic cystic neoplasms
 17 August 2017 
Survival after primary tumor resection in advanced colorectal cancer
 16 August 2017 
Assessment of seronegative villous atrophy
 16 August 2017 
Appendectomy and colectomy risk in ulcerative colitis
 16 August 2017 
Gluten sensitivity and celiac disease
 15 August 2017 
Infliximab and treatment failure during maintenance
 15 August 2017 
Genetic in idiopathic pancreatitis
 15 August 2017 
Genetic factors and tobacco in IBD
 14 August 2017 
Per oral endoscopic myotomy
 14 August 2017 
Early colonoscopy and symptomatic colorectal cancer
 14 August 2017 
Ethnic disparities and Hep C survival
 11 August 2017 
Ledipasvir and sofosbuvir in treatment-naïve Hep C
 11 August 2017 
EBV DNA to screen for nasopharyngeal cancer
 11 August 2017 
Direct acting antivirals and mixed cryoglobulinemia
 10 August 2017 
Routine preoperative laboratory tests for elective surgery
 10 August 2017 

Whole-genome sequencing in primary care

 10 August 2017 
Mortality in cirrhosis
 09 August 2017 
Anticoagulants in cirrhosis
 09 August 2017 
Low birthweight and pediatric NAFLD
 09 August 2017 
IBS with extraintestinal somatic and psychological symptoms
 08 August 2017 
Prior Barrett’s diagnosis and esophageal cancer survival
 08 August 2017 
Imaging index for fistulizing Crohn's
 08 August 2017 
Statin use after colon cancer
 07 August 2017 
Contraindications of biologic therapies in IBD
 07 August 2017 
Predicting clinical outcome in colorectal cancer
 07 August 2017 
Future burden of esophageal cancer
 04 August 2017 
Internet decision-making resources for ulcerative colitis surgery
 04 August 2017 
Distal findings and proximal colorectal neoplasia
 04 August 2017 
CT colonography vs flexible sigmoidoscopy
 03 August 2017 
Bloating and abdominal distension
 03 August 2017 
Predictors of colectomy in ulcerative colitis
 03 August 2017 
Treatment for sensitized transplant patients
 02 August 2017 
Preventing reactivation of Hep B
 02 August 2017 
Improving medication adherence in IBD
 02 August 2017 
Multiply recurrent C. difficile in the USA
 01 August 2017 
Coping with IBD
 01 August 2017 
Hepatocellular carcinoma in autoimmune hepatitis
 01 August 2017 
Anti-TNF treatment in Crohn's disease
 31 July 2017 
Global HCV incidence and mortality elimination targets
 31 July 2017 
Diagnosing GERD
 31 July 2017 
Diagnostic accuracy of severe liver fibrosis in patients with NAFLD
 28 July 2017 
Low FODMAP diet in IBS
 28 July 2017 
IBD patient–centered medical home
 28 July 2017 
Excluding NAFLD in the general population

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us